• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用基于似然估计的连续抗体阳性率数据估算英格兰 A/H1N1 2009 流感感染的年龄特异性发病率。

Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation.

机构信息

Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, London, United Kingdom.

出版信息

PLoS One. 2011 Feb 23;6(2):e17074. doi: 10.1371/journal.pone.0017074.

DOI:10.1371/journal.pone.0017074
PMID:21373639
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3044152/
Abstract

Estimating the age-specific incidence of an emerging pathogen is essential for understanding its severity and transmission dynamics. This paper describes a statistical method that uses likelihoods to estimate incidence from sequential serological data. The method requires information on seroconversion intervals and allows integration of information on the temporal distribution of cases from clinical surveillance. Among a family of candidate incidences, a likelihood function is derived by reconstructing the change in seroprevalence from seroconversion following infection and comparing it with the observed sequence of positivity among the samples. This method is applied to derive the cumulative and weekly incidence of A/H1N1 pandemic influenza in England during the second wave using sera taken between September 2009 and February 2010 in four age groups (1-4, 5-14, 15-24, 25-44 years). The highest cumulative incidence was in 5-14 year olds (59%, 95% credible interval (CI): 52%, 68%) followed by 1-4 year olds (49%, 95% CI: 38%, 61%), rates 20 and 40 times higher respectively than estimated from clinical surveillance. The method provides a more accurate and continuous measure of incidence than achieved by comparing prevalence in samples grouped by time period.

摘要

估算新出现病原体的特定年龄发病率对于了解其严重程度和传播动力学至关重要。本文描述了一种使用似然来从连续血清学数据估算发病率的统计方法。该方法需要有关血清转化率间隔的信息,并允许整合来自临床监测的病例时间分布信息。在候选发病率的一系列中,通过从感染后的血清转化中重建血清阳性率的变化,并将其与样本中观察到的阳性序列进行比较,得出似然函数。该方法应用于使用 2009 年 9 月至 2010 年 2 月之间在四个年龄组(1-4、5-14、15-24 和 25-44 岁)中采集的血清,推导出英格兰在第二波期间 A/H1N1 大流行性流感的累积和每周发病率。5-14 岁儿童的累积发病率最高(59%,95%可信区间[CI]:52%,68%),其次是 1-4 岁儿童(49%,95%CI:38%,61%),分别比临床监测估计的发病率高 20 倍和 40 倍。与按时间段分组的样本中比较流行率相比,该方法提供了更准确和连续的发病率衡量标准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f5/3044152/2303d4173e54/pone.0017074.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f5/3044152/f25ccc5b91c1/pone.0017074.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f5/3044152/6f953cc7a115/pone.0017074.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f5/3044152/ec5b66ee024d/pone.0017074.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f5/3044152/2303d4173e54/pone.0017074.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f5/3044152/f25ccc5b91c1/pone.0017074.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f5/3044152/6f953cc7a115/pone.0017074.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f5/3044152/ec5b66ee024d/pone.0017074.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f5/3044152/2303d4173e54/pone.0017074.g004.jpg

相似文献

1
Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation.使用基于似然估计的连续抗体阳性率数据估算英格兰 A/H1N1 2009 流感感染的年龄特异性发病率。
PLoS One. 2011 Feb 23;6(2):e17074. doi: 10.1371/journal.pone.0017074.
2
Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.评估新型甲型 H1N1 流感病毒在不同年龄段的基线抗体流行率和感染发病率。
Health Technol Assess. 2010 Dec;14(55):115-92. doi: 10.3310/hta14550-03.
3
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.2009 年甲型 H1N1 流感大流行在英格兰的感染发病率:一项横断面血清学研究。
Lancet. 2010 Mar 27;375(9720):1100-8. doi: 10.1016/S0140-6736(09)62126-7. Epub 2010 Jan 21.
4
Interpreting Seroepidemiologic Studies of Influenza in a Context of Nonbracketing Sera.在非配对血清背景下解读流感血清流行病学研究。
Epidemiology. 2016 Jan;27(1):152-8. doi: 10.1097/EDE.0000000000000408.
5
Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011.2010 年和 2011 年英格兰甲型 H1N1pdm09 流感病毒抗体的血清阳性率。
Emerg Infect Dis. 2012 Nov;18(11):1894-7. doi: 10.3201/eid1811.120720.
6
Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.在 2009 年大流行的第一波期间感染甲型 H1N1pdm09:来自孟加拉国达卡的纵向血清流行病学研究的证据。
Influenza Other Respir Viruses. 2017 Sep;11(5):394-398. doi: 10.1111/irv.12462. Epub 2017 Jul 26.
7
Serological survey of 2009 H1N1 influenza in residents of Beijing, China.中国北京居民中 2009 年 H1N1 流感的血清学调查。
Epidemiol Infect. 2011 Jan;139(1):52-8. doi: 10.1017/S0950268810002189. Epub 2010 Sep 21.
8
Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis.英国 2009 年大流行性 A/H1N1 流感严重程度的变化:贝叶斯证据综合分析。
BMJ. 2011 Sep 8;343:d5408. doi: 10.1136/bmj.d5408.
9
Pandemic influenza A/H1N1 2009 antibodies in the metropolitan area of Buenos Aires in Argentina.阿根廷布宜诺斯艾利斯都会区2009年甲型H1N1大流行性流感抗体情况
Int J Infect Dis. 2014 Feb;19:20-5. doi: 10.1016/j.ijid.2013.09.021. Epub 2013 Nov 6.
10
Seroprevalence of antibodies to influenza A/H1N1/2009 among transmission risk groups after the second wave in Mexico, by a virus-free ELISA method.应用无病毒 ELISA 法检测墨西哥第二波疫情后传播风险人群中抗流感 A/H1N1/2009 抗体的血清阳性率。
Int J Infect Dis. 2011 Nov;15(11):e781-6. doi: 10.1016/j.ijid.2011.07.002. Epub 2011 Aug 19.

引用本文的文献

1
Influenza and other respiratory viral infections associated with absence from school among schoolchildren in Pittsburgh, Pennsylvania, USA: a cohort study.美国宾夕法尼亚州匹兹堡地区在校学生因流感和其他呼吸道病毒感染而缺课的情况:一项队列研究。
BMC Infect Dis. 2021 Mar 22;21(1):291. doi: 10.1186/s12879-021-05922-1.
2
Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis.评估下一代 RSV 干预策略:一项数学建模研究和成本效益分析。
BMC Med. 2020 Nov 18;18(1):348. doi: 10.1186/s12916-020-01802-8.
3
Seasonal influenza: Modelling approaches to capture immunity propagation.

本文引用的文献

1
Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.评估新型甲型 H1N1 流感病毒在不同年龄段的基线抗体流行率和感染发病率。
Health Technol Assess. 2010 Dec;14(55):115-92. doi: 10.3310/hta14550-03.
2
The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.2009 年甲型 H1N1 流感在香港的感染发病率和严重程度。
Clin Infect Dis. 2010 Nov 15;51(10):1184-91. doi: 10.1086/656740.
3
Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling.
季节性流感:捕捉免疫传播的建模方法。
PLoS Comput Biol. 2019 Oct 28;15(10):e1007096. doi: 10.1371/journal.pcbi.1007096. eCollection 2019 Oct.
4
Real-time estimation of the influenza-associated excess mortality in Hong Kong.实时估计香港流感相关超额死亡率。
Epidemiol Infect. 2019 Jan;147:e217. doi: 10.1017/S0950268819001067.
5
The impact of stratified immunity on the transmission dynamics of influenza.分层免疫对流感传播动力学的影响。
Epidemics. 2017 Sep;20:84-93. doi: 10.1016/j.epidem.2017.03.003. Epub 2017 Mar 12.
6
Retrospective forecasting of the 2010-2014 Melbourne influenza seasons using multiple surveillance systems.利用多个监测系统对2010 - 2014年墨尔本流感季节进行回顾性预测。
Epidemiol Infect. 2017 Jan;145(1):156-169. doi: 10.1017/S0950268816002053. Epub 2016 Sep 27.
7
CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.关于流感血清流行病学研究报告的简明声明(ROSES-I声明):加强观察性研究报告规范(STROBE)声明的扩展
Influenza Other Respir Viruses. 2017 Jan;11(1):2-14. doi: 10.1111/irv.12411. Epub 2016 Aug 9.
8
Reconstructing a spatially heterogeneous epidemic: Characterising the geographic spread of 2009 A/H1N1pdm infection in England.重建空间异质疫情:描述英格兰 2009 年 A/H1N1pdm 感染的地理传播。
Sci Rep. 2016 Jul 11;6:29004. doi: 10.1038/srep29004.
9
Using Combined Diagnostic Test Results to Hindcast Trends of Infection from Cross-Sectional Data.利用联合诊断检测结果从横断面数据中推断感染趋势。
PLoS Comput Biol. 2016 Jul 6;12(7):e1004901. doi: 10.1371/journal.pcbi.1004901. eCollection 2016 Jul.
10
Model-based reconstruction of an epidemic using multiple datasets: understanding influenza A/H1N1 pandemic dynamics in Israel.利用多数据集基于模型的疫情重建:了解以色列甲型H1N1流感大流行动态
J R Soc Interface. 2016 Mar;13(116). doi: 10.1098/rsif.2016.0099.
需要研究解决 2009 年 H1N1 流感大流行带来的公共卫生挑战:建模的启示。
PLoS Med. 2010 Jun 1;7(6):e1000275. doi: 10.1371/journal.pmed.1000275.
4
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.AS03B 佐剂裂解病毒与无佐剂全病毒 H1N1 流感疫苗在英国 6 个月至 12 岁儿童中的安全性和免疫原性:开放标签、随机、平行组、多中心研究。
BMJ. 2010 May 27;340:c2649. doi: 10.1136/bmj.c2649.
5
Real-time epidemic monitoring and forecasting of H1N1-2009 using influenza-like illness from general practice and family doctor clinics in Singapore.利用新加坡普通科门诊和家庭医生诊所的流感样疾病进行 H1N1-2009 的实时疫情监测和预测。
PLoS One. 2010 Apr 14;5(4):e10036. doi: 10.1371/journal.pone.0010036.
6
Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.英格兰大流行性流感 A/H1N1v 疫苗接种:实时经济评价。
Vaccine. 2010 Mar 11;28(12):2370-84. doi: 10.1016/j.vaccine.2010.01.002. Epub 2010 Jan 21.
7
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.2009 年甲型 H1N1 流感大流行在英格兰的感染发病率:一项横断面血清学研究。
Lancet. 2010 Mar 27;375(9720):1100-8. doi: 10.1016/S0140-6736(09)62126-7. Epub 2010 Jan 21.
8
Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study.2009年甲型H1N1流感大流行在英格兰导致的死亡率:公共卫生监测研究
BMJ. 2009 Dec 10;339:b5213. doi: 10.1136/bmj.b5213.
9
The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis.2009 年 4 月至 7 月美国大流行性 H1N1 流感的严重程度:贝叶斯分析。
PLoS Med. 2009 Dec;6(12):e1000207. doi: 10.1371/journal.pmed.1000207. Epub 2009 Dec 8.
10
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.2009 年甲型 H1N1 流感单价 MF59 佐剂疫苗试验。
N Engl J Med. 2009 Dec 17;361(25):2424-35. doi: 10.1056/NEJMoa0907650. Epub 2009 Sep 10.